PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
about
sameAs
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxarP2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activationRacial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376cPulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis.Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by raceImpaired activation of platelets lacking protein kinase C-theta isoformProteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactPlatelet thrombin receptor antagonism and atherothrombosisPlatelet biology and implications for antiplatelet therapy in atherothrombotic disease.Antiplatelet therapy: thrombin receptor antagonists.Atopaxar: a review of its mechanism of action and role in patients with coronary artery disease.Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.
P2860
Q27016071-1E452234-95A0-4BD2-A6C9-05B24234866DQ28194880-90679BDC-C0A6-48BC-B369-5CA76524FAF2Q30558959-E939C3D8-0E3E-4509-931E-7C8420A22B36Q33390301-F475D573-7F4B-4877-8F75-BA5F7CDB8A60Q34550588-5EE68287-CE90-44C8-9458-3B0FD85F0518Q34560219-9BD1CE5F-32D0-47AC-A340-918ABC326148Q34580117-156819D0-BBC6-4CE3-94C3-19454E1846DCQ37129685-19E7FEA4-2AF0-4E5A-B06D-6C3B9759B471Q37348262-EC7D15FC-6214-4B18-923C-685A423EB096Q37641556-9D94A55A-54F4-4126-9FDE-75C3FAC3A5E0Q37766688-4A4B453D-999D-4341-A593-A8CEF4158B15Q37929838-44F2E501-C795-4771-B1E9-6BAAC3B41181Q38032614-EC9FC038-C5D0-4C7F-A966-9090FD99437DQ39649606-6A23FA58-B18A-4D07-BEB2-390A4F7B974E
P2860
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@ast
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@en
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@nl
type
label
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@ast
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@en
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@nl
prefLabel
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@ast
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@en
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@nl
P1476
PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets
@en
P2093
Ruth Ann Henriksen
Vallere K Hanks
P356
10.1161/01.ATV.0000014742.56572.25
P407
P577
2002-05-01T00:00:00Z